Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Under Pressure
Trending lower, slight contraction.
Left:
||||
Year-over-year gross profit growth rate
Latest
43.20%
Near historical average
Average (39q)
44.84%
Historical baseline
Range
High:961.52%
Low:-84.86%
CAGR
-7.6%
Structural decline
| Period | Value |
|---|---|
| Q3 2025 | 43.20% |
| Q2 2025 | 521.68% |
| Q1 2025 | -84.86% |
| Q4 2024 | 46.60% |
| Q3 2024 | -34.57% |
| Q2 2024 | 92.40% |
| Q1 2024 | -58.26% |
| Q4 2023 | 3.82% |
| Q3 2023 | 29.25% |
| Q2 2023 | -15.58% |
| Q1 2023 | -2.89% |
| Q4 2022 | -1.31% |
| Q3 2022 | 11.77% |
| Q2 2022 | 11.72% |
| Q1 2022 | -25.75% |
| Q4 2021 | 25.78% |
| Q3 2021 | 1.06% |
| Q2 2021 | 25.23% |
| Q1 2021 | -36.64% |
| Q4 2020 | 41.59% |
| Q3 2020 | -7.90% |
| Q2 2020 | 14.27% |
| Q1 2020 | -32.60% |
| Q4 2019 | -11.77% |
| Q3 2019 | 43.74% |
| Q2 2019 | 34.30% |
| Q1 2019 | -38.03% |
| Q4 2018 | 78.86% |
| Q3 2018 | -20.73% |
| Q2 2018 | 15.77% |
| Q1 2018 | -21.78% |
| Q4 2017 | 5.37% |
| Q3 2017 | 31.13% |
| Q2 2017 | 19.25% |
| Q1 2017 | -39.67% |
| Q4 2016 | 199.48% |
| Q3 2016 | 26.08% |
| Q2 2016 | -33.72% |
| Q1 2016 | -24.26% |
| Q4 2015 | 961.52% |